SEC Filings

10-Q
AVEXIS, INC. filed this Form 10-Q on 08/10/2017
Entire Document
 

AveXis, Inc.

 

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 

 

 

    

2017

    

2016

 

Cash flows from operating activities

 

 

 

 

 

 

 

Net loss

 

$

(87,748)

 

$

(36,555)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

729

 

 

27

 

Stock-based compensation

 

 

13,257

 

 

17,387

 

Changes in operating assets and liabilities

 

 

 

 

 

 

 

Prepaid and other current assets

 

 

(4,306)

 

 

(2,119)

 

Other long-term assets

 

 

(1,155)

 

 

(731)

 

Accounts payable

 

 

3,457

 

 

795

 

Accrued expenses and other current liabilities

 

 

1,089

 

 

866

 

Accrued indemnification obligation

 

 

(1,675)

 

 

 

Net cash used in operating activities

 

 

(76,352)

 

 

(20,330)

 

Cash flows from investing activities

 

 

 

 

 

 

 

Capital expenditures

 

 

(16,758)

 

 

(7,503)

 

Net cash used in investing activities

 

 

(16,758)

 

 

(7,503)

 

Cash flows from financing activities

 

 

 

 

 

 

 

Proceeds from issuance of common stock, net of issuance costs

 

 

270,256

 

 

98,170

 

Payments of deferred offering costs

 

 

 —

 

 

(1,198)

 

Proceeds from exercise of stock options

 

 

461

 

 

 —

 

Service-based restricted stock unit vesting

 

 

(417)

 

 

 —

 

Proceeds from exercise of stock warrants

 

 

 —

 

 

42

 

Net cash provided by financing activities

 

 

270,300

 

 

97,014

 

Net increase in cash and cash equivalents

 

 

177,190

 

 

69,181

 

Cash and cash equivalents, Beginning of Period

 

 

240,430

 

 

62,252

 

Cash and cash equivalents, End of Period

 

$

417,620

 

$

131,433

 

Supplemental Cash Flow Information

 

 

 

 

 

 

 

Capital expenditures in accounts payable and accrued liabilities

 

$

4,936

 

$

578

 

Accrued unpaid issuance costs associated with June 2017 public offering

 

$

518

 

$

 —

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

5


 


© AveXis, Inc. All Rights Reserved.